P035 Ozanimod for Moderate-to-Severe Ulcerative Colitis: North American Population Results During Induction and Maintenance in the Phase 3 True North Study.
Author
Hudesman, DavidLong, Millie
Wolf, Douglas
Hanauer, Stephen
Ghosh, Subrata
Petersen, AnnKatrin
Pondel, Marc
Silver, Michael
Cross, Raymond
Feagan, Brian
Date
2021-12Journal
American Journal of GastroenterologyPublisher
Wolters Kluwer HealthType
Article
Metadata
Show full item recordRights/Terms
Copyright © 2021 by The American College of Gastroenterology.Identifier to cite or link to this item
http://hdl.handle.net/10713/17530ae974a485f413a2113503eed53cd6c53
10.14309/01.ajg.0000798740.67469.6e